Appili Therapeutics Inc. (TSX:APLI)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Sep 3, 2026, 4:10 PM EST
Appili Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -4.69 | -4.24 | -2.62 | -3.78 | -9.24 | -25.12 |
Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Loss (Gain) From Sale of Assets | - | - | - | -0 | 0.02 | 0 |
Stock-Based Compensation | 0.04 | 0.05 | 0.12 | 0.19 | 0.88 | 2.04 |
Other Operating Activities | 1.04 | 0.75 | 3.59 | 0.45 | 1.47 | 1.5 |
Change in Accounts Receivable | -0.45 | -0.13 | -0.5 | -1.04 | 0.35 | 0.57 |
Change in Accounts Payable | 2.63 | 2.23 | 0.19 | 1.38 | -4.16 | 1.92 |
Change in Other Net Operating Assets | 0.05 | -0.01 | 0.08 | 0.04 | -0.05 | 0.27 |
Operating Cash Flow | -1.37 | -1.34 | 0.87 | -2.46 | -10.1 | -19.08 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | - | - | -0 | -0.03 | -0 | - |
Sale of Property, Plant & Equipment | - | - | - | 0 | - | - |
Investment in Securities | - | - | - | - | - | 5.06 |
Investing Cash Flow | - | - | -0 | -0.03 | -0 | 5.06 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | - | 0.4 | 0.3 | 2.5 | 8 |
Long-Term Debt Repaid | - | -0.06 | -0.14 | -0.1 | -0.09 | -4.17 |
Net Debt Issued (Repaid) | -0.03 | -0.06 | 0.26 | 0.2 | 2.41 | 3.83 |
Issuance of Common Stock | 0.28 | 0.28 | - | - | 3.21 | 5.39 |
Other Financing Activities | 0.12 | -0.07 | -0.06 | -0.08 | 0.28 | 0.35 |
Financing Cash Flow | 0.36 | 0.15 | 0.19 | 0.12 | 5.91 | 9.56 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 0.02 | -0 | 0.07 | 0 | -0.01 | 0.06 |
Net Cash Flow | -0.99 | -1.19 | 1.13 | -2.37 | -4.2 | -4.4 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -1.37 | -1.34 | 0.87 | -2.49 | -10.1 | -19.08 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -377.83% | -547.72% | 862.63% | -301.44% | -3022.65% | -1372.07% |
Free Cash Flow Per Share | -0.01 | -0.01 | 0.01 | -0.02 | -0.09 | -0.29 |
Levered Free Cash Flow | -2.54 | -3 | -8.53 | -5.22 | -7.37 | -11.74 |
Unlevered Free Cash Flow | -1.61 | -1.92 | -6.69 | -4.2 | -6.77 | -10.77 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 0.03 | 0.05 | 0.06 | 0.07 | 0.48 | 0.09 |
Cash Income Tax Paid | - | - | - | - | 0.01 | - |
Change in Working Capital | 2.24 | 2.1 | -0.23 | 0.66 | -3.24 | 2.49 |